Summary
No clear evidence supports routine percutaneous coronary intervention (PCI) for patients with diabetes and multivessel disease, according to 5-year follow-up data from the Coronary Artery Revascularisation in Diabetes [CARDia; ISRCTN19872154] trial. Coronary artery bypass graft surgery is favored, unless clinical features indicate that PCI is clearly preferable.
- Interventional Techniques & Devices
- Cardiology Clinical Trials
- Diabetes Mellitus
- Coronary Artery Disease
- © 2012 MD Conference Express®
Tools
Table of contents
Cited By...
- No citing articles found.